超6成私募产品业绩创新高！15只“双十基金”产品在列！盛丰私募旗下产品排名居前！

Core Insights - The private equity products have reached record highs in performance, with 60.43% of the 2761 products achieving historical net value highs in July 2025 [1][2] - The A-share market showed a strong upward trend in July 2025, with the Shanghai Composite Index rising by 3.74%, the Shenzhen Component Index by 5.20%, and the ChiNext Index by 8.14% [1] - The majority of high-performing products are equity strategy products, particularly subjective long and quantitative long strategies, which account for approximately 60% of the total [1][2] Product Types - Among the 2761 private equity products, 1214 are quantitative products and 1547 are non-quantitative products [1] - The top strategy is equity strategy products, with 1654 products, followed by multi-asset strategy products (393), futures and derivatives strategy products (327), bond strategy products (290), and combination fund products (97) [1] Company Scale - The largest number of high-performing products comes from private equity firms with assets under management (AUM) below 500 million, totaling 1122 products, which is over 40% of the total [2] - There are 379 products from firms with AUM exceeding 10 billion [2] Long-Established Products - Among the high-performing products, 21 have been established for over 10 years, with 15 of them being subjective long products and 3 being quantitative CTA products [2] - Notably, 15 of these long-established products have annualized returns exceeding 10% [2] Performance Rankings - The article lists the top-performing products in various strategies, including equity, multi-asset, futures, and bond strategies, highlighting their respective managers and performance metrics [4][5][10][15][19][23] - For example, the top products in the subjective long strategy are from Nengjing Investment Holdings, while the leading products in the quantitative long strategy are from companies like Jingqi Investment and Huanrong Investment [10][15] Market Outlook - The current market conditions are described as being in the second phase of a bull market, characterized by a focus on quality growth stocks, particularly in sectors like innovative pharmaceuticals, AI, and stablecoin financial innovations [5]